Buyue Y - Search Results

1

Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.

Sommer JM, Moore N, McGuffie-Valentine B, Bardan S, Buyue Y, Kamphaus GD, Konkle BA, Pierce GF. Sommer JM, et al. Among authors: buyue y. Haemophilia. 2014 Mar;20(2):294-300. doi: 10.1111/hae.12296. Epub 2013 Nov 22. Haemophilia. 2014. PMID: 24261554 Free PMC article.

2

Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity.

Sommer JM, Buyue Y, Bardan S, Peters RT, Jiang H, Kamphaus GD, Gray E, Pierce GF. Sommer JM, et al. Among authors: buyue y. Thromb Haemost. 2014 Nov;112(5):932-40. doi: 10.1160/TH13-11-0971. Epub 2014 Aug 21. Thromb Haemost. 2014. PMID: 25144892 Free PMC article.

3

A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activity.

Buyue Y, Liu T, Kulman JD, Toby GG, Kamphaus GD, Patarroyo-White S, Lu Q, Reidy TJ, Mei B, Jiang H, Pierce GF, Sommer JM, Peters RT. Buyue Y, et al. PLoS One. 2014 Nov 21;9(11):e113600. doi: 10.1371/journal.pone.0113600. eCollection 2014. PLoS One. 2014. PMID: 25415306 Free PMC article.

4

Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.

Toby GG, Liu T, Buyue Y, Zhang X, Bitonti AJ, Pierce GF, Sommer JM, Jiang H, Peters RT. Toby GG, et al. Among authors: buyue y. PLoS One. 2016 Feb 3;11(2):e0148255. doi: 10.1371/journal.pone.0148255. eCollection 2016. PLoS One. 2016. PMID: 26840952 Free PMC article.

5

Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.

Buyue Y, Misenheimer TM, Sheehan JP. Buyue Y, et al. J Thromb Haemost. 2012 Oct;10(10):2086-98. doi: 10.1111/j.1538-7836.2012.04892.x. J Thromb Haemost. 2012. PMID: 22905983 Free PMC article.

6

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.

Buyue Y, Whinna HC, Sheehan JP. Buyue Y, et al. Blood. 2008 Oct 15;112(8):3234-41. doi: 10.1182/blood-2008-01-136820. Epub 2008 Jul 22. Blood. 2008. PMID: 18647957 Free PMC article.

7

Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal.

Buyue Y, Misenheimer TM, Sheehan JP. Buyue Y, et al. J Thromb Haemost. 2013 Mar;11(3):565-6. doi: 10.1111/jth.12136. J Thromb Haemost. 2013. PMID: 23332108 Free article. No abstract available.

8

The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.

Misenheimer TM, Buyue Y, Sheehan JP. Misenheimer TM, et al. Among authors: buyue y. Biochemistry. 2007 Jul 3;46(26):7886-95. doi: 10.1021/bi7004703. Epub 2007 Jun 12. Biochemistry. 2007. PMID: 17563121

9

Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.

Buyue Y, Sheehan JP. Buyue Y, et al. Blood. 2009 Oct 1;114(14):3092-100. doi: 10.1182/blood-2009-02-203661. Epub 2009 May 4. Blood. 2009. PMID: 19414859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters